1.
Muttaqin FZ, Fahlevi R, Muhammad HN. In silico study of aminothiazole, benzohydrazide, namoline, piridine, and parnate derivatives as Jumonji domain histone lysine demethylase (KDM1A, KDM4A, KDM4C, KDM4E, AND KDM5B) inhibitors in prostate cancer. Pharm Educ [Internet]. 2023 Jun. 9 [cited 2024 May 11];23(2):p. 253-259. Available from: https://pharmacyeducation.fip.org/pharmacyeducation/article/view/2170